![](/img/cover-not-exists.png)
Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives
Wislez, Marie, Giroux-Leprieur, Etienne, Fallet, Vincent, Cadranel, JacquesLanguage:
english
Journal:
Lung Cancer: Targets and Therapy
DOI:
10.2147/lctt.s99303
Date:
June, 2016
File:
PDF, 473 KB
english, 2016